Results 141 to 150 of about 20,413 (188)

Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole-N-Oxide Exposure. [PDF]

open access: yesMycoses
Hubrechts J   +9 more
europepmc   +1 more source

Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events. [PDF]

open access: yesFront Child Adolesc Psychiatry
Gándara-Mireles JA   +7 more
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). [PDF]

open access: yesBr J Clin Pharmacol
Dello Russo C   +22 more
europepmc   +1 more source

CYP2D6- en CYP2C19-genotypering

open access: yesTijdschrift voor Psychiatrie, 2021
Koopmans, A. B.   +3 more
openaire   +1 more source

Studies Based on CYP2C19 Genotypes

open access: yesRinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2013
Takahisa FURUTA, Mitsushige SUGIMOTO
openaire   +2 more sources

Association Between <i>CYP2C9</i> and <i>CYP2C19</i> Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy. [PDF]

open access: yesPharmaceuticals (Basel)
Alvarado AT   +18 more
europepmc   +1 more source

Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics. [PDF]

open access: yesAntimicrob Agents Chemother
Zhu Y   +12 more
europepmc   +1 more source

Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis. [PDF]

open access: yesFront Pharmacol
Mohammed S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy